In cancer cells, the OXPHOS inhibition activates the LKB1–AMPK pathway, thus inhibiting the Raptor–mTOR complex (mammalian TOR complex 1 (mTORC1)) and the tuberous sclerosis complex 2 (TSC2) [21]. This evidence concerns the gene MTOR and cancer.